Treatment Market to Record an Exponential CAGR by 2022, according to Global Purpura
Treatment Market Analysis Report published by Market Research Future (MRFR).
The present study reports a single case of a patient with Henoch-Schonlein purpura
nephritis associated with IgA-[kappa]MGRS that was gradually improved by dexamethasone and bortezomib chemotherapy.
Idiopathic thrombocytopenic purpura
is an autoimmune disease in which the person has reduced platelets caused by the production of autoantibody against individual's platelet.
In a letter to Kline's lawyer obtained by The WaPo, Purpura
wrote that a committee subpoena asking Kline to appear "unconstitutionally encroaches on fundamental executive branch interests".
Witty, friendly, and provocative, Purpura
fosters a belief in the authenticity of interaction.
Reconstituting," writes Lia Purpura
. This is just one of the luminous themes mined in her glittering new essay collection All the Fierce Tethers.
Healthcare company Sanofi (EURONEXT:SAN) (NASDAQ:SNY) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura
(aTTP) in adults.
(HSP), also called anaphylactoid purpura
, is a subtype of small-vessel vasculitis where immunoglobulin A (IgA) is deposited in the vessel walls.
Thrombotic thrombocytopenic purpura
(TTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction.
This abnormally low count may subsequently manifest itself as an excessive internal or external bleed, easy bruisability (purpura
) or oozing of blood from vessels into the skin and mucous membranes (petechiae).5 ITP can be classified clinically as newly diagnosed/acute (diagnosis to 3 months), persistent (3 to 12 months) and chronic (lasting for more than 12 months).6 It is a self-limiting condition and may not require any treatment.
Objective: To assess clinical presentation and outcome of patients with thrombotic thrombocytopenic purpura
(TTP) in our setup.